High osteoporotic fracture risk and CVD risk co-exist in postmenopausal women

被引:16
|
作者
Makovey, Joanna [1 ]
Macara, Monique [1 ]
Chen, Jian Sheng [1 ]
Hayward, Christopher S. [2 ,3 ]
March, Lyn [1 ]
Sambrook, Philip N. [1 ]
机构
[1] Univ Sydney, Inst Bone & Joint Res, Kolling Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia
[2] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia
[3] Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Bone mineral density; FRAX; OS fracture risk; Hip fracture risk; Framingham Risk Equation; CVD risk; BONE-MINERAL DENSITY; CORONARY-HEART-DISEASE; OPPOSITE-SEX TWIN; CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; VASCULAR CALCIFICATION; SERUM-CHOLESTEROL; CLINICAL-PRACTICE; BODY-COMPOSITION; ABDOMINAL-AORTA;
D O I
10.1016/j.bone.2012.09.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Osteoporosis related risk factors such as BMD have been associated with cardiovascular endpoints in previous studies but there have been no studies of integrated risk using risk factor algorithms. Methods: A sample of 358 peri- and postmenopausal women, mean age 59.3 (range 45-74) years were studied. Each individual had bone mineral density (BMD) measurements by dual energy X-ray absorptiometiy. Fracture risk was assessed using the WHO FRAX algorithm and cardiovascular disease (CVD) risk using the Framingham Risk Tool. Results: Women with higher 10 year risk of major osteoporotic had significantly higher cardiovascular risk (4.634% vs 8.36%, p=0.001). In multiple regression analysis, 5-year CVD risk was significantly associated with the 10-year risk of having major osteoporotic (beta=0.095, p=0.001) and hip (beta=0.055, p=0.001) fracture. Women with the highest CVD risk were 5.4 times more likely to have higher risk of major osteoporotic fracture. Conclusions: Fracture risk, determined by using a multiple risk factor algorithm such as FRAX, was positively associated with higher cardiovascular risk determined by using the Framingham Risk Tool. Awareness regarding these concurrent risk factors needs to be raised so that appropriate risk reduction can be implemented. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 50 条
  • [21] Postmenopausal osteoporotic women around the world are at high risk for vitamin D inadequacy
    Hosking, D
    Holick, M
    Lips, P
    Turpin, J
    Petruschke, RA
    Chen, E
    De Papp, A
    Chandler, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 92 - 92
  • [22] CARDIOVASCULAR RISK FACTORS AND INCIDENCE OF CARDIOVASCULAR EVENTS IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE
    Elhussein, L.
    Khalid, S.
    Moayyeri, A.
    Pisa, F. P.
    Toth, E.
    Libanati, C.
    Prieto-Alhambra, D.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S552 - S552
  • [23] EFFICACY OF BAZEDOXIFENE IN REDUCING THE INCIDENCE OF NONVERTEBRAL FRACTURES IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN AT HIGHER FRACTURE RISK
    Silverman, Stuart L.
    Christiansen, Claus
    Genant, Harry K.
    Zanchetta, Jose R.
    Vukicevic, Slobodan
    Valter, Ivo
    de Villiers, Tobie J.
    Ciesielska, Monika
    Chines, Arkadi A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S192 - S193
  • [24] Efficacy of Bazedoxifene in Reducing the Incidence of Nonvertebral Fractures in Postmenopausal Osteoporotic Women at Higher Fracture Risk
    Brown, Jacques P.
    Kendler, David L.
    Silverman, Stuart L.
    Christiansen, Claus
    Genant, Harry K.
    Zanchetta, Jose R.
    Vukicevic, Slobodan
    Valter, Ivo
    de Villiers, Tobie J.
    Ciesielska, Monika
    Chines, Arkadi A.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2566 - 2566
  • [25] RELATIONSHIP BETWEEN OBESITY AND RISK OF MAJOR OSTEOPOROTIC FRACTURE IN POSTMENOPAUSAL WOMEN: TAKING FRAILTY INTO CONSIDERATION
    Li, G.
    Li, Z.
    Thabane, L.
    Adachi, J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S48 - S49
  • [26] EFFICACY OF BAZEDOXIFENE IN REDUCING THE INCIDENCE OF NONVERTEBRAL FRACTURES IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN AT HIGHER FRACTURE RISK
    Silverman, S.
    Christiansen, C.
    Genant, H.
    Zanchetta, J.
    Vukicevic, S.
    Valter, I.
    de Villiers, T.
    Ciesielska, M.
    Chines, A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 101 - 101
  • [27] Relationship Between Obesity and Risk of Major Osteoporotic Fracture in Postmenopausal Women: Taking Frailty Into Consideration
    Li, Guowei
    Compston, Juliet E.
    Leslie, William D.
    Thabane, Lehana
    Papaioannou, Alexandra
    Lau, Arthur
    Wang, Xiaojie
    Qin, Chenghe
    Chen, Bo
    Chen, Maoshui
    Adachi, Jonathan D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (12) : 2355 - 2362
  • [28] Association of FLT3 Polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women
    Koh, Jung-Min
    Oh, Bermseok
    Lee, Jong-Young
    Lee, Jong-Keuk
    Kimm, Kuchan
    Park, Byung Lae
    Shin, Hyoung Doo
    Lee, Il-Kwon
    Kim, Hyeoung-Joon
    Hong, Jung-Min
    Kim, Tae-Ho
    Kim, Ghi Su
    Kim, Shin-Yoon
    Park, Eui Kyun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) : 1752 - 1758
  • [29] A TOOL TO IDENTIFY POSTMENOPAUSAL WOMEN WITH HIGH FRACTURE RISK IN SRI LANKA
    Subasinghe, H.
    Lekamwasam, S.
    Ball, P.
    Morrissey, H.
    Waidyaratne, E. I.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S552 - S553
  • [30] EFFICACY AND SAFETY OF ABALOPARATIDE IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRAGILITY FRACTURE
    Harvey, N. C.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S581 - S581